FDA Adverse Event Injury Summary report: N

ALTRX NEUT 32IDX52OD

MDR report key: 3202635 · Received July 2, 2013

Report

Report Number
1818910-2013-20408
Event Type
Injury
Date Received
July 2, 2013
Date of Event
January 1, 2013
Report Date
June 5, 2013
Manufacturer
DEPUY ORTHOPAEDICS, INC.
Product Code
LPH
PMA / PMN Number
PK072963
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. A SEARCH OF THE COMPLAINT DATABASE AND/OR DHR REVIEW WAS NOT POSSIBLE AS THE PRODUCT AND LOT CODE REQUIRED WAS NOT PROVIDED. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT WITH THE INFORMATION AVAILABLE. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ANY ADDITIONAL INFORMATION BE RECEIVED TO CHANGE THE OUTCOME OF THE PERFORMED INVESTIGATION, THE COMPLAINT WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATIONS. MEDICAL RECORDS WERE RECEIVED AND REVIEWED. WITH THE INFORMATION PROVIDED, IT CANNOT BE DETERMINED THAT THE IMPLANTS CONTRIBUTED TO THE REPORTED EVENTS. THE INVESTIGATION CAN DRAW NO CONCLUSIONS WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO DETERMINE ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION HAS NOT BEEN INDICATED.

Additional Manufacturer Narrative · 1

THE COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

LEGAL CLAIM RECEIVED. IT IS ALLEGED THAT THE PATIENT WAS IMPLANTED WITH PINNACLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
301312 ALTRX NEUT 32IDX52OD HIP LINER LPH DEPUY ORTHOPAEDICS, INC. 167465

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention